Centene Corp is primarily active in the healthcare and managed care industries.

The main competitors of Centene Corp in the market include UnitedHealth Group, Anthem Inc., Humana Inc., and CVS Health Corporation.

Centene Corp is a leading healthcare enterprise in the United States. Founded in 1984, the company has steadily grown to become a well-established player in the industry. Centene Corp focuses on providing comprehensive healthcare solutions to its members, ranging from Medicaid and Medicare programs to commercial insurance and individual insurance plans. With a strong commitment to improving access to high-quality healthcare, Centene Corp serves millions of individuals across the country. The company's history is marked by its dedication to innovation and collaboration, aiming to deliver cost-effective and patient-centered care. Centene Corp continues to evolve and expand its services, making it a prominent name in the healthcare sector.

Centene Corp has achieved significant milestones over the years. One notable achievement is its inclusion in the Fortune 500 list, which showcases the company's success and prominence. Furthermore, Centene has expanded its presence through strategic acquisitions, enhancing its market position and diversifying its offerings. The company's commitment to innovation and delivering high-quality healthcare services has earned it recognition, such as being named one of the World's Most Admired Companies in the healthcare industry. Centene Corp continues to strive for excellence, constantly seeking ways to improve patient outcomes and reshape the healthcare landscape.

Centene Corp is primarily present in the United States. As a leading healthcare enterprise, Centene operates across various states and serves millions of individuals through government-sponsored programs such as Medicaid and Medicare. With a comprehensive network of health plans and providers, Centene offers its services to diverse populations in areas including urban, rural, and underserved communities. By leveraging its expertise in managing healthcare benefits, Centene strives to improve access to quality care and enhance overall health outcomes for its members throughout the United States.

Centene Corp represents a commitment to providing high-quality healthcare services to individuals and communities in need. The company's corporate philosophy focuses on improving the health of its members by offering comprehensive, innovative, and cost-effective solutions. Centene prioritizes a patient-centric approach, ensuring access to affordable healthcare options and personalized care. With a strong emphasis on collaboration and integrity, Centene embraces diversity and inclusivity in its workforce and community partnerships. By delivering value-based care and promoting social responsibility, Centene Corp strives to improve health outcomes and enhance the overall well-being of its members and their communities.

Analysts currently set an average price target of 46,34 USD for the Centene stock (median: 43,86 USD), implying −29,5 % versus the latest price. The consensus is based on 26 analyst ratings.

Centene Analyytikkojen kursstavoitteet 2026

26 analysts currently rate the Centene stock: 8 recommend buying, 16 holding and 2 selling. For 2026, analysts expect Centene to generate revenue of 191,16 Mrd. USD and earnings per share of 3,53 USD.

Centene Analyytikkojen kursstavoitteet 2026

Converted at the current exchange rate, the Centene share trades at 56,92 EUR (65,77 USD).

The Centene share (CNC) is listed on 8 stock exchanges, including: NYSE (CNC), Frankfurt (QEN.F), München (QEN.MU), Düsseldorf (QEN.DU), London (0HVB.L), London (0HVB.L), SIX (Zürich) (QEN.SW).

Centene Corp is a multinational company based in the USA that specializes in providing medical services for low-income individuals. The company has been operating since 1984 and is headquartered in St. Louis, Missouri. It employs over 70,000 employees and operates in 25 US states and the international market. Centene Corp has gained a good reputation in the market and is considered a leader in the industry.

odotettu liikevaihto Centene on 191,16 Mrd. USD. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.

odotettu voitto Centene on 1,73 Mrd. USD. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.

Centene:n hinta-voitto-suhde (P/E) on tällä hetkellä 18,64. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Centene-osakkeen arvostusta.

Centene:n hinta-myynti-suhde (P/S) on tällä hetkellä 0,17. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Centene-osakkeen arvostuskennuslukuna.

Centene:n Eulpool-laatuscore on 3/10.

Centene:n ISIN on US15135B1017. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.

Centene:n WKN on 766458. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.

Centene:n ticker on CNC. Tämä pörssinoteeraus käytetään Centene-osakkeiden kauppaan pörssissä.

Centene maksoi osinkoa joka vuosi viimeisten 0 vuoden aikana.

Centene kuuluu sektoriin 'Terveydenhuolto'.

Centene:n osingot jaetaan valuutassa USD.